2021 日本专家共识：精神分裂症的药物治疗

2021-01-12 Pharmacopsychiatry . 2021 Jan 12.

由13名专家组成的JSCNP医学教育专家组确定了19个既往文献未能充分回答的课题，并邀请全部会员参与调研，最终形成了精神分裂症药物治疗专家共识。

中文标题：

英文标题：

Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus

发布机构：

发布日期：

2021-01-12

简要介绍：

由13名专家组成的JSCNP医学教育专家组确定了19个既往文献未能充分回答的课题，并邀请全部会员参与调研，最终形成了精神分裂症药物治疗专家共识。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=95ba21c0020615dd, title=2021 日本专家共识：精神分裂症的药物治疗, enTitle=Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus, guiderFrom=Pharmacopsychiatry . 2021 Jan 12., authorId=0, author=, summary=由13名专家组成的JSCNP医学教育专家组确定了19个既往文献未能充分回答的课题，并邀请全部会员参与调研，最终形成了精神分裂症药物治疗专家共识。, cover=https://img.medsci.cn/2021215/1613319616697_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Jan 12 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>由13名专家组成的JSCNP医学教育专家组确定了19个既往文献未能充分回答的课题，并邀请全部会员参与调研，最终形成了精神分裂症药物治疗专家共识。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=1344, tagName=精神分裂症)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1344, guiderKeyword=精神分裂症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13095, appHits=289, showAppHits=0, pcHits=1751, showPcHits=12806, likes=1, shares=13, comments=19, approvalStatus=1, publishedTime=Mon Feb 15 00:20:37 CST 2021, publishedTimeString=2021-01-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Feb 15 00:20:22 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 13:32:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 日本专家共识：精神分裂症的药物治疗.pdf)])

2021 日本专家共识：精神分裂症的药物治疗.pdf

下载请点击：

评论区 (18)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2215714, encodeId=72f52215e14e3, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15a25314353, createdName=148947e7m76(暂无昵称), createdTime=Fri Jul 19 10:29:21 CST 2024, time=2024-07-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208325, encodeId=0b2b1208325c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Sun Apr 03 10:51:35 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079346, encodeId=d5ea10e9346e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:38:25 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058586, encodeId=6b33105858690, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91735627987, createdName=ms6000000677539406, createdTime=Fri Oct 08 12:55:05 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006922, encodeId=3b8d10069226b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 11 11:43:49 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
2024-07-19 148947e7m76(暂无昵称) 来自北京

感谢

58 0
[GetPortalCommentsPageByObjectIdResponse(id=2215714, encodeId=72f52215e14e3, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15a25314353, createdName=148947e7m76(暂无昵称), createdTime=Fri Jul 19 10:29:21 CST 2024, time=2024-07-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208325, encodeId=0b2b1208325c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Sun Apr 03 10:51:35 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079346, encodeId=d5ea10e9346e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:38:25 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058586, encodeId=6b33105858690, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91735627987, createdName=ms6000000677539406, createdTime=Fri Oct 08 12:55:05 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006922, encodeId=3b8d10069226b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 11 11:43:49 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
2022-04-03 1881eacd07m

学习了

91 0
[GetPortalCommentsPageByObjectIdResponse(id=2215714, encodeId=72f52215e14e3, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15a25314353, createdName=148947e7m76(暂无昵称), createdTime=Fri Jul 19 10:29:21 CST 2024, time=2024-07-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208325, encodeId=0b2b1208325c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Sun Apr 03 10:51:35 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079346, encodeId=d5ea10e9346e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:38:25 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058586, encodeId=6b33105858690, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91735627987, createdName=ms6000000677539406, createdTime=Fri Oct 08 12:55:05 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006922, encodeId=3b8d10069226b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 11 11:43:49 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
2021-12-12 ms8000001575079939

学习

115 0
[GetPortalCommentsPageByObjectIdResponse(id=2215714, encodeId=72f52215e14e3, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15a25314353, createdName=148947e7m76(暂无昵称), createdTime=Fri Jul 19 10:29:21 CST 2024, time=2024-07-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208325, encodeId=0b2b1208325c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Sun Apr 03 10:51:35 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079346, encodeId=d5ea10e9346e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:38:25 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058586, encodeId=6b33105858690, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91735627987, createdName=ms6000000677539406, createdTime=Fri Oct 08 12:55:05 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006922, encodeId=3b8d10069226b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 11 11:43:49 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
2021-10-08 ms6000000677539406

学习

107 0
[GetPortalCommentsPageByObjectIdResponse(id=2215714, encodeId=72f52215e14e3, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15a25314353, createdName=148947e7m76(暂无昵称), createdTime=Fri Jul 19 10:29:21 CST 2024, time=2024-07-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1208325, encodeId=0b2b1208325c9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0eb2046086, createdName=1881eacd07m, createdTime=Sun Apr 03 10:51:35 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079346, encodeId=d5ea10e9346e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46325544295, createdName=ms8000001575079939, createdTime=Sun Dec 12 23:38:25 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058586, encodeId=6b33105858690, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91735627987, createdName=ms6000000677539406, createdTime=Fri Oct 08 12:55:05 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006922, encodeId=3b8d10069226b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbd15570111, createdName=ms5000000793547615, createdTime=Wed Aug 11 11:43:49 CST 2021, time=2021-08-11, status=1, ipAttribution=)]
2021-08-11 ms5000000793547615

学习

90 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

精神心理科指南

2021 日本专家共识：精神分裂症的药物治疗

相关指南

拓展阅读

科室

工具

服务